Skip to main content
Pentixapharm Holding AG logo

Pentixapharm Holding AG — Investor Relations & Filings

Ticker · PTP ISIN · DE000A40AEG0 LEI · 3912005VBOVXNDXEQZ36 F Manufacturing
Open in API
Filings indexed 62 across all filing types
Latest filing 2025-11-12 Interim / Quarterly Rep…
Country DE Germany
Listing F PTP

About Pentixapharm Holding AG

https://www.pentixapharm.com/

Pentixapharm Holding AG is a clinical-stage company focused on developing first-in-class radiopharmaceuticals. The company's research and development centers on CXCR4 ligand-based compounds for diagnostic and therapeutic applications. Its clinical pipeline features two drug candidates that are ready for Phase III trials. One of its lead assets is the radiodiagnostic candidate 68Ga-PentixaFor, which is being prepared for a Phase 3 study for applications in hypertension. The company's core CXCR4 compound has been extensively studied, administered to over 2,000 patients, and is the subject of more than 150 scientific publications.

Recent filings

Filing Released Lang Actions
Q3 statement / Q3 financial report 2025
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the nine-month period ending September 30, 2025. It includes an 'Interim Group Management Report', 'Interim Consolidated Financial Statements' (including income statement, balance sheet, cash flows, and notes), and a statement by legal representatives. It contains substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2025
2025-11-12 English
Pentixapharm to Report Third Quarter and First Nine Months 2025 Financial Results on Wednesday, November 12, 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) informing the public that Pentixapharm Holding AG will publish its financial results for the third quarter and first nine months of 2025 on a future date (November 12, 2025). It provides details for an upcoming conference call and webcast. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2025-11-10 English
Pentixapharm Holding AG: Pentixapharm significantly reduces projected loss for financial year 2025
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc' disclosure of inside information regarding a revision to the company's projected financial loss for the 2025 fiscal year. It provides key financial highlights (a reduction in projected loss from €23.5 million to €18 million) rather than a full financial report. This fits the definition of an Earnings Release (ER), which covers initial announcements of financial results or updates to financial guidance. FY 2025
2025-11-06 English
Pentixapharm Holding AG: Eckert Wagniskapital und Fruhphasenfinanzierung GmbH, buy
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person closely associated with a member of the administrative or supervisory body (Dr. Andreas Eckert). It explicitly uses the header 'Directors’ Dealings' and follows the standard regulatory format for disclosing insider transactions, including the name of the person, the nature of the transaction (acquisition), the financial instrument (shares), and the price/volume details. This fits the definition of a Director's Dealing (DIRS) filing.
2025-11-06 English
Report Publication Announcement 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 2,000 characters) titled 'Preliminary announcement of the publication of quarterly reports and quarterly/interim statements'. It explicitly states that the company will disclose financial reports on a future date (November 12, 2025) and provides links to where they will be available. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, making it a Report Publication Announcement (RPA).
2025-11-03 English
Hinweis auf Zwischenmitteilung der Geschäftsführung vom 01.07.2025 bis zum 30.09.2025
Report Publication Announcement Classification · 100% confidence The document is a short notification (788 characters) announcing the availability of an interim management statement for the period 01.07.2025 to 30.09.2025. It provides a link to the website where the actual report can be found and specifies the publication date. Per the 'Menu vs Meal' rule, since this is a short announcement regarding the publication of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2025-11-03 German

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.